Meadow Creek Investment Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Meadow Creek Investment Management’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$15K	Hold	1,680	–	–	﹤0.01%	1335
2019 Q2	$18K	Buy	+1,680	New	+$17.9K	﹤0.01%	1332
2019 Q1	–	Sell	-22,540	Closed	-$259K	–	1356
2018 Q4	$259K	Sell	22,540 -9,884	-30%	-$123K	0.01%	865
2018 Q3	$550K	Buy	32,424 +15,568	+92%	+$237K	0.01%	688
2018 Q2	$239K	Buy	16,856 +12,656	+301%	+$210K	0.01%	939
2018 Q1	$80K	Buy	+4,200	New	+$89.8K	﹤0.01%	1237

Other funds holding SGMO

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Meadow Creek Investment Management's SGMO Position: Q3 2019 in Review

Meadow Creek Investment Management held its SANGAMO THERAPEUTICS INC (SGMO) position steady in Q3 2019 at 1,680 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #1335.

Meadow Creek Investment Management first reported a position in SGMO in Q1 2018 and has held it in 6 quarters since. The position peaked at $550K in Q3 2018. 184 funds tracked by Wall St. Rank hold SGMO as of Q3 2019.

Meadow Creek Investment Management held 1,680 shares of SANGAMO THERAPEUTICS INC worth $15K as of Q3 2019.
Meadow Creek Investment Management left its SANGAMO THERAPEUTICS INC share count unchanged in Q3 2019.
SANGAMO THERAPEUTICS INC made up ﹤0.01% of Meadow Creek Investment Management's portfolio in Q3 2019, its #1335 holding.
Meadow Creek Investment Management first reported a position in SANGAMO THERAPEUTICS INC in Q1 2018 and has held it in 6 quarters since.
Meadow Creek Investment Management's SANGAMO THERAPEUTICS INC position peaked at $550K in Q3 2018.
184 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.